The roles of sphingosine kinases SK1 and SK2 in ischemia-reperfusion injury have not been fully elucidated since studies have found beneficial effects of SK1 while others showed no role in this injury. To help resolve this, we used SK1 or SK2 knockout mice and confirmed that renal ischemia-reperfusion injury induced SK1, but not SK2, in the kidneys. Furthermore, knockout or pharmacological inhibition of SK1 increased injury after renal ischemiareperfusion injury. In contrast, lack of SK2 conferred renal protection following injury. In addition, we used lentiviral gene delivery to selectively express enhanced green fluorescent protein (EGFP) or human SK1 coexpressed with EGFP (EGFP-huSK1) in the kidney. Mice with kidney-specific overexpression of EGFP-huSK1 had significantly improved renal function with lower plasma creatinine, renal necrosis, apoptosis, and inflammation. Moreover, EGFP-huSK1 overexpression in cultured human proximal tubule (HK-2) cells protected against peroxide-induced necrosis. Selective overexpression of EGFP-huSK1 led to increased HSP27 mRNA and protein expression in vivo and in vitro. Functional protection as well as induction of HSP27 with EGFP-huSK1 overexpression in vivo was blocked with sphingosine-1-phosphate-1 receptor 1 (S1P 1 ) antagonism. Thus, our findings suggest that SK1 is renoprotective by S1P 1 activation and perhaps HSP27 induction. Kidney-specific expression of SK1 through lentiviral delivery may be a viable therapeutic option to attenuate renal ischemia-reperfusion injury.
Renal ischemia-reperfusion injury (IRI) is a significant cause of acute kidney injury (AKI), a major clinical problem often leading to multiorgan dysfunction and systemic inflammation. 1 The development of AKI is associated with increased morbidity and mortality among patients in the intensive care setting, 2 and AKI requiring renal replacement therapy is an independent predictor of mortality after cardiac surgery. 3 Despite continued research on renal protective agents, there are no proven therapies to reduce AKI in the perioperative setting. 4 Sphingosine kinase (SK) is an important regulator of cellular signaling pathways and exists in two isoforms. 5, 6 SK leads to the formation of sphingosine-1-phosphate (S1P), a lysophospholipid functioning as both an extracellular ligand for specific Gprotein-coupled receptors and an intracellular second messenger in promoting cell growth and survival and the inhibition of apoptosis. 5, 7 Activation of the S1P 1 receptor (S1P 1 ) has been shown to be protective in cardiac 8 and renal IRI, [9] [10] [11] but the roles of SK1 and SK2 in IRI are controversial and have yet to be fully elucidated. A recent study suggests that constitutive expression of SK2 may contribute to reduced injury with no role for SK1 after renal IRI. 12 However, in acute lung injury, SK1 was protective and SK2 led to increased injury. Furthermore, in cardiac IRI, SK1 activation has a potent cytoprotective role. 13 In this study, we determined the specific role of SK enzyme subtypes in renal IRI. We tested the hypothesis that SK1 activation is renoprotective and that selective renal overexpression of SK1 would improve renal function and reduce necrosis, inflammation, and apoptosis after IRI in mice. We used genetically modified strains of mice lacking SK1 (SK1 À/À ) and SK2 (SK2 À/À ) enzyme to study the effects of SK subtypes in renal IRI. In addition, we used intrarenal gene delivery in mice with a lentiviral vector that expresses either enhanced green fluorescent protein (EGFP) or human SK1 coexpressing EGFP (EGFP-huSK1), as well as cultured human proximal tubule (HK-2) cells infected with EGFP or EGFP-huSK1 lentivirus.
RESULTS

Differential induction of SK activity and mRNA regulation after renal IRI
We initially measured baseline renal SK activity in wild-type (WT), SK1
À/À , and SK2 À/À sham-operated mice ( Figure 1a ).
SK1
À/À and SK2 À/À mice are congenically derived on a C57BL/6 background. Compared with WT mice, SK2 À/À mice had similar renal SK activity at baseline, whereas SK1 À/À mice had a large decrease (approximately threefold) in baseline renal SK activity. With 30 min of renal ischemia and 24 h of reperfusion (renal IRI), renal SK activity markedly increased (B4-5-fold) in WT mice and SK2 À/À mice compared with sham-operated mice. In contrast, SK1
À/À mice subjected to renal IRI had no increase in renal SK activity compared with SK1 À/À sham-operated mice. These results demonstrate that there was a significant and selective upregulation of SK1 and not SK2 activity in mice in response to renal IRI.
Similarly, there were increased SK1 mRNA levels in WT and SK2
À/À mice after renal IRI compared with shamoperated mice (Figure 1b , representative of four experiments). However, SK2 mRNA levels in WT and SK1 À/À mice were unchanged after renal IRI compared with shamoperated mice, further confirming selective renal SK1 upregulation in response to renal IRI. À/À (middle panels), and SK2 À/À (bottom panels) mice subjected to 20 min of renal IRI. (e) Plasma creatinine in mice pretreated with vehicle or the SK inhibitors SKI-II (50 mg/kg subcutaneously (s.c.)) or CAY10621 (2 mg/kg intravenously (i.v.)) and subjected to sham operation, 20 min of IRI, or 30 min of IRI, followed by 24 h of reperfusion (N ¼ 6 per group). For all graphs: **Po0.001 vs. WT sham group; *Po0.001 vs. respective sham groups; N ¼ 3) mice. Plasma creatinine levels were also similar (although slightly elevated compared with mice not subjected to surgery) in sham-operated (anesthesia, laparotomy, right nephrectomy, and recovery) WT, SK1 À/À , and SK2 À/À mice ( Figure 1c ). Plasma creatinine increased in WT, SK1 À/À , and SK2 À/À mice subjected to moderate (20 min) or severe (30 min) renal IRI compared with sham-operated mice. After both moderate and severe renal IRI, SK1 À/À mice had significantly increased renal injury compared with WT or SK2
À/À mice with higher plasma creatinine levels. In contrast, SK2 deficiency provided renal protection as SK2 À/À mice had significantly lower plasma creatinine levels compared with WT and SK1 À/À mice after moderate or severe renal IRI. Figure 1d demonstrates histological injury in mice after 20 min of renal IRI. Compared with shamoperated mice (data not shown), the kidneys of WT mice developed mild injury with some tubular vacuolization and proteinaceous casts (Figure 1d , top panels). SK1
À/À mice developed more severe injury with increased tubular dilatation and congestion, vacuolization, and simplification ( Figure 1d , middle panels). SK2 À/À mice had markedly reduced injury compared with SK1 À/À mice ( Figure 1d , bottom panels).
Because of the inherent concerns regarding the use of genetic knockout mice (for example, alterations in the expression of unrelated proteins), we treated some WT mice with a selective but nonspecific SK inhibitor (SKI-II) or an SK1-specific inhibitor (CAY10621) before induction of renal IRI. We determined that SKI-II inhibited mouse kidney SK activity in a dose-dependent manner (inhibition of 25 ± 2% and 85 ± 3% at 25 and 250 mg/ml, respectively, N ¼ 4), and preliminary experiments (N ¼ 3) showed that the dose of SKI-II used in our study reduced plasma S1P levels in mice by 470%. In addition, vehicle, SKI-II, or CAY10621 administration had no detrimental effects on renal function in shamoperated mice (Figure 1e ). Mice subjected to moderate (20 min) or severe (30 min) renal IRI with SKI-II or CAY10621 treatment had increased plasma creatinine levels compared with vehicle-treated mice (Figure 1e ), providing further evidence that blocking the induction of SK1 activity worsened renal function after IRI.
We also demonstrate that administration of a selective S1P 1 agonist, SEW2871 (20 mg/kg p.o. 3 h before ischemia and 9 h after reperfusion), protected mice against renal IRI. The vehicle used to administer SEW2871 (10% dimethylsulfoxide, 25% Tween-20) had no effects on renal function in sham-operated mice (Cr ¼ 0.52 ± 0.01 mg/dl, N ¼ 3), but caused an increase in plasma creatinine after renal IRI compared with mice not treated with vehicle (Cr ¼ 3.38±0.07 mg/dl, N ¼ 7 vs. 2.45±0.10 mg/dl, N ¼ 8, Po0.001). However, when mice were treated with SEW2871, there was a significant decline in plasma creatinine (Cr ¼ 2.34 ± 0.04 mg/dl, N ¼ 8, Po0.001 vs. vehicle IRI). Taken together, our results indicate that SK1 has protective effects (most likely via S1P 1 activation), whereas SK2 contributes to worsening renal injury after renal IRI.
In vivo renal expression of EGFP or EGFP-huSK1 after intrarenal lentiviral gene delivery in WT mice
We used lentiviral constructs encoding EGFP or EGFP-huSK1 to selectively express these gene products in the kidneys of WT mice. Intrarenal lentivirus injection had no adverse effects in mice. As previously demonstrated, [14] [15] [16] intrarenal delivery of lentivirus encoding EGFP or EGFP-huSK1 resulted in robust expression of EGFP in the corticomedullary junction (primarily S3 segments of proximal tubules as the major tubular segment represented) at 48 h after injection (Figure 2a , left panels, representative of four experiments) with minimal EGFP expression (similar to baseline green autofluorescence) in the contralateral (noninjected) kidney (data not shown).
To confirm that the cells expressing EGFP-SK1 protein are proximal tubules, we performed Phaseolus vulgaris leucoagglutinin lectin staining in kidney sections. The brush border of proximal tubules stained heavily with P. vulgaris leucoagglutinin lectin (red, Figure 2a , middle panels), and the merged images demonstrate that nearly all of the EGFP-expressing cells are proximal tubules (Figure 2a , right panels). Brush-border stains were lush, consistent with S3 segment morphology.
We confirmed the expression of EGFP and huSK1 mRNA in mice renally injected with EGFP and EGFP-huSK1 lentivirus using reverse transcriptase-PCR. Figure 2b (representative of four experiments) shows that the kidneys of mice injected with a lentiviral construct all expressed EGFP mRNA. In contrast, only EGFP-huSK1-injected mice expressed huSK1 mRNA. We failed to detect EGFP or huSK1 mRNA in the contralateral (noninjected) kidneys of lentivirus-injected mice (Figure 2b ) as demonstrated previously. [14] [15] [16] There were similar SK activity levels in the kidneys of mice not subjected to lentiviral injection (data not shown), the contralateral (noninjected) kidneys (Figure 2c ), or the kidneys renally injected with EGFP lentivirus (Figure 2c ). However, when mice were renally injected with EGFP-huSK1 lentivirus, there was a significant increase in renal SK activity, confirming that the lentiviral construct encoded functional huSK1 enzyme (Figure 2c ).
We measured S1P levels in the injected kidneys (cortex and corticomedullary junction tissue) and plasma of mice after lentiviral injection using high-performance liquid chromatography. Compared with kidneys injected with EGFP lentivirus, there was a significant increase in renal S1P levels after renal injection with EGFP-huSK1 lentivirus (S1P level ¼ 2.73±0.32-fold compared with EGFP lentivirus-injected samples, N ¼ 3, Po0.05). However, plasma levels of S1P were not different in mice injected with EGFP lentivirus compared with mice injected with EGFP-huSK1 lentivirus (S1P level ¼ 0.95 ± 0.18-fold compared with EGFP lentivirus-injected samples, N ¼ 3).
Renal protection with EGFP-huSK1 expression in mice
Mice renally injected with EGFP or EGFP-huSK1 lentivirus and subjected to sham operation had normal plasma creatinine similar to mice without lentiviral injection Kidney International (2011) 80, 1315-1327 ( Figure 3 ). Mice without lentiviral injection or mice renally injected with EGFP lentivirus 48 h prior had similar and significant increases in plasma creatinine after 30 min of renal ischemia and 24 h of reperfusion compared with shamoperated mice. In contrast, mice renally injected with lentivirus encoding EGFP-huSK1 showed significant renal protection after renal IRI. The protective effects of EGFPhuSK1 lentivirus were mediated via S1P 1 as treatment with an S1P 1 -specific antagonist (W146) given before renal IRI reversed the protection seen in mice renally injected with EGFP-huSK1 lentivirus (Figure 3 ). compared with mice injected with EGFP lentivirus and mice not subjected to lentiviral injection. The Jablonski scale renal injury score histology grading 17 was used to grade renal tubular necrosis after renal IRI ( Figure 4e ). Mice injected with EGFP or EGFP-huSK1 encoding lentivirus and subjected to sham operation developed very mild tubular necrosis compared with shamoperated mice not subjected to lentiviral injection. Renal ischemia for 30 min and reperfusion for 24 h resulted in severe acute tubular necrosis in mice subjected to renal IRI and in mice injected with lentivirus encoding EGFP 48 h before renal IRI. In contrast, mice renally injected with lentivirus encoding EGFP-huSK1 48 h before renal IRI had significantly lower renal injury scores compared with mice injected with lentivirus encoding EGFP and mice not subjected to lentiviral injection ( Figure 4e ).
Mice renally expressing EGFP-huSK1 show reduced proinflammatory gene expression in the kidney after renal IRI
There were no differences in the mRNA expressions of tumor necrosis factor-a, intercellular adhesion molecule-1, monocyte chemoattractive protein-1, macrophage inflammatory protein-2, and interleukin-6 between sham-operated mice renally injected with EGFP lentivirus or EGFP-huSK1 lentivirus ( Figure 5 ). We found significantly increased mRNA expression of these proinflammatory genes in mice subjected to renal IRI after renal injection with EGFP lentivirus compared with sham-operated mice. However, mice renally injected with EGFP-huSK1 lentivirus before renal IRI had significantly reduced expression of these proinflammatory mRNAs compared with EGFP lentivirus-injected mice undergoing renal IRI. experiments) expressions in mice. As expected, renal IRI led to an increase in HSP27 expression as EGFP lentivirusinjected mice subjected to renal IRI had higher HSP27 mRNA (B2-fold) and protein (B10-fold) expression than EGFP lentivirus-injected mice subjected to sham operation. Surprisingly, in sham-operated mice, EGFP-huSK1 lentiviral injection alone led to a sharp increase in HSP27 mRNA (B6-fold) and protein (B3-fold) compared with mice injected with EGFP lentivirus. Furthermore, induction of HSP27 mRNA (B2.4-fold) and protein (B2.2-fold) were enhanced even further in EGFP-huSK1 lentivirus mice subjected to renal IRI compared with mice renally injected with EGFP lentivirus and subjected to renal IRI. Finally, induction of HSP27 with EGFP-huSK1 lentiviral injection ( Figure 8c , mRNA and protein) was lost when mice were treated with the S1P 1 antagonist W146 before and after EGFP-huSK1 lentivirus injection. We also found that EGFP-huSK1 HK-2 cells had significantly increased HSP27 and SK1 mRNA expression (Figure 9a , representative of four experiments) and protein expression (Figure 9b , representative of four experiments) compared with EGFP HK-2 cells.
DISCUSSION
The major findings of this study are as follows: (1) renal IRI led to significant upregulation of SK1 mRNA expression and activity in the kidney, whereas SK2 was not affected; (2) this induction of SK1 was important in mediating protective effects after renal IRI, as both SK1 À/À mice and mice treated with the SK inhibitor SKI-II or the selective SK1 inhibitor CAY10621 had increased renal injury, whereas SK2 À/À mice had a reduction in injury; (3) selective renal overexpression of huSK1 protected mice against renal IRI in vivo via activation of S1P 1 ; and (4) SK1 overexpression resulted in induction of HSP27 mRNA and protein expression in vivo and in vitro.
AKI remains a significant clinical problem in the perioperative period, and the development of postoperative AKI requiring renal replacement therapy carries a 60% mortality rate. 19 AKI is an inflammatory process involving multiple cellular and systemic responses, including activation of proinflammatory cytokines and chemokines, 20 and infiltration by leukocytes such as neutrophils, macrophages, and T cells. 21 The inflammatory response is not limited to the kidney, but affects other organ systems, including the liver, 22 intestine, 22 lung, 23 and heart. 24 Multiorgan dysfunction associated with AKI leads to greatly increased morbidity and mortality. 25 Our studies demonstrate a renal protective role for SK1, and intrarenal lentiviral delivery of SK1 may be a therapeutic option to protect against renal IRI. SK, the enzyme catalyzing the conversion of sphingosine to S1P, is an important regulator of the putative 'sphingolipid rheostat' that balances the cytoprotective effects of S1P against the proapoptotic effects of ceramide and sphingosine.
7,26 S1P binds to specific G-protein-coupled receptors, of which five are known (S1P 1À5 ). 7 The exact roles for the two subtypes of SK in tissue injury and survival remain controversial. Of the two known isoforms, SK1 is primarily known to be cytoprotective, promoting cell survival via the generation of S1P that signals in an autocrine/paracrine manner to mediate S1P-receptor-activated signaling. 27 The role of SK2 is not as clear as some studies demonstrate a proapoptotic and antiproliferative role for SK2, [28] [29] [30] which may function independently of S1P receptors, 31 whereas other studies show an antiapoptotic role for SK2, as inhibiting SK2 or suppressing its expression enhanced apoptosis in various cancer cells. 32 Complicating matters further, some experimental models demonstrate a proinflammatory role of SK1, as SK inhibition 33 or mice lacking SK1 enzyme 34 had reduced inflammation and colon damage in a model of Crohn's disease, and blockade of SK1 reduced the inflammatory response in endotoxin-mediated sepsis. 35 Despite these differences, there is redundancy between SK1 and SK2 as both SK1 À/À and SK2 À/À mice have no gross phenotypic abnormalities, whereas mice lacking both SK1 and SK2 are not viable. 36, 37 The regulation of SK varies depending on the organ. Cardiac IRI downregulated SK1 activity but did not affect SK2 in the hearts of mice. 13 In the lung, both SK1 and SK2 were upregulated after lipopolysaccharide-induced acute lung injury. 38 The role that each SK subtype has in renal IRI is not fully elucidated. We have previously demonstrated that the volatile anesthetic isoflurane increased plasma membrane translocation of SK1 to mediate protection against renal IRI in mice. 39 In contrast, a recent study by Jo et al. 12 suggests that although SK1 was upregulated after renal IRI, mice lacking SK1 did not have increased renal dysfunction after renal IRI. On the contrary, a lack of SK2 resulted in increased renal injury and neutrophil infiltration after renal IRI. 12 We confirm in this study that only SK1 is upregulated in the kidney after renal IRI. However, we demonstrate a protective role for endogenous SK1 and a detrimental role for endogenous SK2 in both models of moderate (20 min) and severe renal ischemia (30 min). We used a model of contralateral nephrectomy with unilateral ischemia, whereas Jo et al. 12 used a model of bilateral ischemia. The model of AKI used may result in different outcomes, as it was previously demonstrated that unilateral or bilateral ischemia resulted in different effects on subsequent resistance of proximal tubules to hypoxia. 40 Differences in anesthetic agents used (pentobarbital in our study vs. ketamine, xylazine, and acepromazine in study by Jo et al.
12
) may impact the outcome after renal IRI as several anesthetics (for example, volatile anesthetics) are known to modulate sphingolipid metabolism. 39, 41 It is possible that operative conditions and/or immunomodulatory effects of anesthetics may affect the outcome of lentiviral overexpression as a therapeutic modality. In addition, the SK2 À/À mice that we used and the SK2 tr/tr mice from the Jo et al. 12 study were obtained from different sources 37, 42 and there may be subtle differences in local laboratory conditions that may affect outcome. It will be necessary to reconcile the differences between our models in future studies. Our findings are consistent with other models of inflammation as mice lacking SK1 had increased injury with ischemic preconditioning in cardiac IRI 13 and mice lacking SK1 enzyme had poor recovery from anaphylaxis with delayed histamine clearance, whereas mice lacking SK2 enzyme had rapid recovery from anaphylaxis. 43 Overexpression of SK1 via adenoviral vectors has been used to demonstrate the protective effects of SK1 in cardiac IRI 44 and acute lung injury. 38 We used a lentiviral vector to selectively and stably express the desired gene products (EGFP and EGFP-huSK1) in the renal cortex and corticomedullary junction of kidneys, [14] [15] [16] as well as in HK-2 cells. 18 There is selective protein expression in injected kidneys when compared with noninjected kidneys, and mice injected with a lentiviral construct show robust expression of the targeted gene products. [14] [15] [16] The main site of injury in our model of warm renal IRI is the corticomedullary junction, composed mainly of S3 segments of the proximal tubule 45, 46 and HK-2 cells correspond to the cell type in the kidney that is most susceptible to necrosis after renal IRI. 47, 48 Using P. vulgaris leucoagglutinin lectin staining to identify proximal tubule brush border, we demonstrated that the majority of cells expressing EGFP were S3 segments of the proximal tubule, the cells most damaged after ischemic injury. Therefore, using our method of lentiviral gene delivery, we were able to directly test the hypothesis that selective expression of huSK1 in the kidney and in HK-2 cells protects against renal IRI in vivo and H 2 O 2 -induced necrosis in vitro.
Selective expression of EGFP-huSK1 protected against renal IRI as evidenced by a marked reduction in plasma creatinine levels. The beneficial effects of renal EGFP-huSK1 expression were dependent on S1P 1 activation, as mice treated with an S1P 1 antagonist were not protected against renal IRI after EGFP-huSK1 lentivirus injection. Indeed, our current and previous studies have implicated the renal protective role of the S1P 1 , as S1P or S1P 1 agonists such as FTY720 or SEW2871 were protective in in vivo models of renal IRI via peripheral lymphopenia [9] [10] [11] and a reduction in early renal T-cell infiltration. 49 However, a recent study showed that the protective effects of S1P 1 agonism occurred independently of lymphocytes through direct effects on renal proximal tubule epithelial cells via activation of the cytoprotective Akt/ERK pathways. 50 Selective expression of EGFP-huSK1 in the kidneys of mice led to an increase in SK activity in the kidney, which resulted in a localized increase in kidney S1P levels, but not in plasma S1P levels. Increased renal S1P after SK1 lentiviral transduction could have decreased leukocyte-mediated renal injury in addition to providing the direct cytoprotective effects on kidney proximal tubule cells via S1P 1 activation after IR. However, it is possible that, as our targeted gene product was of human origin, cellular regulation of huSK1 may be different from regulation of endogenous murine SK1.
The renal protection occurring with EGFP-huSK1 lentiviral injection was associated with a decrease in the renal expression of proinflammatory cytokines, including tumor necrosis factor-a, intercellular adhesion molecule-1, monocyte chemoattractive protein-1, macrophage inflammatory protein-2, and interleukin-6. In addition, there was reduced neutrophil infiltration, as well as significantly less renal tubular necrosis of the 'outer stripe' of the outer medulla, and reduced renal tubular apoptosis. Consistent with the finding of increased plasma creatinine in SK1 À/À mice, there were significant increases in the kidney expression of some proinflammatory mRNAs in SK1 À/À mice after renal IRI compared with WT mice (data not shown). We also confirmed our previous finding that HK-2 cells overexpressing huSK1 were protected against H 2 O 2 -induced necrosis. 18 In our study, selective overexpression of huSK1 strongly induced HSP27 in the kidney and in HK-2 cells, which was reversed with S1P 1 blockade, suggesting an additional potential mechanism of cytoprotection with SK1 overexpression. As we used an overexpression model of huSK1, we must be cautious in implicating this pathway as the only protective mechanism in the physiology of the normal mouse. It is possible that HSP27 may be one of several protective factors that the SK1-S1P 1 pathway regulates to induce renal protection after IRI. HSPs are a group of molecular chaperones that are upregulated after various cellular stresses, including heat shock, hypoxia, ischemia, and toxin exposures. 51, 52 Increased HSP27 expression protects a cell from injury or death by functioning as a chaperone to facilitate proper polypeptide folding, assembly of oligomers, transport, and conformational changes. We recently demonstrated that selective renal overexpression of HSP27 in the kidney protected mice against renal IRI by increasing F-actin cytoskeletal preservation. 15 In addition, translocation of SK1 to the plasma membrane has been shown to be coordinated with the actin cytoskeleton in macrophages. 53 The induction of HSP27 by SK1 could enhance cytoskeletal integrity allowing translocation and activation of SK1. S1P has been shown to induce HSP27 via the p38 mitogenactivated protein kinase 54 and the phosphatidylinositol 3-kinase/Akt 55, 56 pathways in osteoblasts. Further study will be necessary to determine the precise relationship between SK1 and HSP27 in mediating renal protection after IRI.
In conclusion, we show in this study that endogenous SK1 had protective effects, whereas endogenous SK2 had deleterious effects in a model of murine renal IRI. In addition, we show that selective renal expression of the EGFP-huSK1 transgene via lentiviral vector is possible in the mouse kidney, and that this selective renal overexpression protects mice against renal IRI via activation of S1P 1 and perhaps via induction of HSP27. These findings may have important clinical implications, as they imply that kidney-specific expression of SK1 through lentiviral delivery is a viable therapeutic option in attenuating the effects of renal IRI. 
MATERIALS AND METHODS
Intrarenal lentivirus delivery in mice
Lentivirus encoding EGFP-huSK1 was generated by subcloning huSK1 cDNA into a modified shuttle vector CMV-pLL3.7, in which the insert expression is driven by a CMV promoter, followed by an IRES-EGFP sequence for simultaneous coexpression of the EGFP reporter gene and hemagglutinin (HA) tag. When expressed, this vector yields two independent proteins, EGFP and the huSK1 protein fused with the HA tag. Lentivirus was produced by a triple transfection of CMV-huSK1-pLL3.7 or CMV-pLL3.7 (10 mg), pVSVG (Vesicular stomatitis virus G; Invitrogen, Carlsbad, CA; 7 mg), and pD8.9 (from Dr Van Parjs, MIT, Cambridge, MA; 5 mg) as previously described. 57, 58 In vivo virus transduction in mice was performed as described. [14] [15] [16] Determination of transgene expression with intrarenal lentivirus injection We detected the expression of EGFP and EGFP-huSK1 48 h after intrarenal injection of lentivirus in mice as described previously. [14] [15] [16] We also identified proximal tubules by labeling kidney cryosections using P. vulgaris leucoagglutinin (PHA-L) lectin as described previously. 59 PHA-L lectin binds avidly to the brush border of proximal tubules. 60 Briefly, fixed cryosections were treated with 0.3% H 2 O 2 in methanol for 10 min, 1% bovine serum albumin for 30 min, and then PHA-L conjugated to a fluorescent dye (Alexa Fluor 594, Invitrogen) for 1 h at room temperature. Overlap of proximal tubules (red) with EGFP expression (green) was examined with an Olympus IX81 (Center Valley, PA) epifluorescence microscope and analyzed with Slidebook software (Intelligent Imaging Innovations, Denver, CO).
We also extracted total RNA from renal cortices and performed reverse transcriptase-PCR assays for EGFP, GAPDH (glyceraldehyde 3-phosphate dehydrogenase), and huSK1 as described previously 58, 61 (Table 1 ). In addition, we confirmed the functional nature of the transgene product by measuring total SK activity as described previously. 39 Briefly, kidney tissues from mice were collected and homogenized in cell lysate buffer (100 mmol/l sucrose, 1 mmol/l EGTA, 20 mmol/l MOPS, pH 7.4, 5% Percoll, 0.01% digitonin, protease (Calbiochem, La Jolla, CA), and phosphatase inhibitors) on ice. After a 1000 g spin for 15 min to pellet cellular debris, protein concentrations were determined and SK activity was measured as described by Vessey et al. 62 Total SK activity was also measured in the kidneys of WT, SK1 À/À , and SK2
À/À mice after sham operation or renal IRI. To confirm our results, we supplemented the assay buffer with 0.5% Triton X-100 or 1 mol/l KCl to create SK1-and SK2-specific assay buffer conditions, respectively, 63 and we found that the rise in SK activity following renal IRI was entirely due to an increase in SK1 activity and not SK2 activity (data not shown). Our results show that mice with only SK2 enzyme (SK1 À/À mice) did not have increased SK2 activity after renal IRI. In contrast, mice with only SK1 enzyme (SK2 À/À mice) had significantly increased SK1 activity after renal IRI (5.9 ± 0.7-fold, N ¼ 3, Po0.05 vs. sham). We measured S1P levels in the kidneys and plasma of mice after lentiviral injection using highperformance liquid chromatography as described previously. 64 Murine model of renal IRI All animal protocols were approved by the institutional animal care and use committee of Columbia University (New York, NY). We used male C57BL/6 (Harlan, Indianapolis, IN) or SK1 À/À and SK2 À/À mice (kindly provided by RL Proia, NIH, Bethesda, MD). The generation and initial characterization of SK1 À/À36 and SK2 À/À37 mice have been described previously. These mice are congenically derived on a C57BL/6 background. In adult (20-25 g ) male C57BL/6, SK1 À/À , or SK2 À/À mice, 20-or thirty-min left renal IRI was performed under pentobarbital anesthesia as described. 65 For lentiviral experiments, renal IRI was performed 48 h after intrarenal injection of EGFP or EGFP-huSK1 lentivirus in C57BL/6 mice as described. 14, 15 All mice underwent right nephrectomy at the time of sham operation or renal IRI.
To test the effects of SK inhibition, the SK inhibitors SKI-II or CAY10621 were administered to mice subjected to renal IRI. SKI-II (50 mg/kg) was administered subcutaneously 15 min before ischemia and 4 h after reperfusion. SKI-II is an SK-selective inhibitor with minimal effects on other kinases, 66 and this dose was shown to have effective inhibition of activity without significant toxicity. 67 CAY10621, an SK1-specific inhibitor with no inhibitory effect on SK2, 68 was administered intravenously (2 mg/kg) 30 min before ischemia. To test the effects of S1P 1 agonism, a selective S1P 1 agonist, SEW2871 (20 mg/kg), was administered to mice 3 h before ischemia and 9 h after reperfusion. SEW2871 was administered via oral gavage in 10% dimethylsulfoxide/25% Tween-20 as it has low solubility in aqueous solution. 10 To test whether S1P 1 antagonism blocked the renal protective effects of huSK1 overexpression, the S1P 1 -specific inhibitor W146 (see ref. 69 69 ) (0.1 mg/kg) was administered intraperitoneally 15 min before sham operation or renal ischemia. To test the effects of S1P 1 antagonism on HSP27 mRNA and protein induction after huSK1 overexpression, W146 was administered intraperitoneally 15 min before and 24 h after lentivirus injection. SKI-II, CAY10621, and W146 were dissolved in 1% dimethylsulfoxide in water (vehicle).
Plasma creatinine level determination
Plasma creatinine levels were measured with an enzymatic creatinine reagent kit according to the manufacturer's instructions (Thermo Fisher Scientific, Waltham, MA).
Histological detection of necrosis
Morphological assessment was performed by an experienced renal pathologist (VDD) who was unaware of the treatment that each animal had received. A grading scale of 0-4, as outlined by Jablonski et al., 17 was used to assess the degree of renal tubular necrosis in the outer medullary area after renal IRI as described previously.
70,71
Detection of renal tubular apoptosis after renal IRI We detected apoptosis after renal IRI with TUNEL staining. In situ labeling of fragmented DNA was performed with TUNEL stain (green fluorescence) using a commercially available in situ cell-death detection kit (Roche, Indianapolis, IN) according to the instructions provided by the manufacturer. TUNEL-positive cells per highpowered field were counted to quantify apoptosis.
Assessment of renal inflammation
Renal inflammation after IRI was determined (1) with detection of neutrophil infiltration with immunohistochemistry 24 h after renal IRI and (2) by measuring mRNA-encoding markers of inflammation, including interleukin-6, intercellular adhesion molecule-1, monocyte chemoattractive protein-1, macrophage inflammatory protein-2, and tumor necrosis factor-a. Immunohistochemistry for Abbreviations: bp, base pairs; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; HSP27, heat shock protein 27; ICAM-1, intercellular adhesion molecule-1; IL-6, interleukin-6; MCP-1, monocyte chemoattractant protein 1; MIP-2, macrophage inflammatory protein 2; SK, sphingosine kinase; TNF-a, tumor necrosis factor-a.
Respective anticipated RT-PCR product size, PCR cycle number for linear amplification, and annealing temperatures used for each primer are also provided. neutrophils was performed as described previously 70, 71 with a monoclonal antibody against PMN (clone 7/4). A primary antibody that recognized IgG 2a (MCA1212, Serotec, Raleigh, NC) was used as a negative isotype control in all experiments. Neutrophils per highpowered field were counted to quantify the degree of neutrophil infiltration. Semiquantitative reverse transcriptase-PCR assays for proinflammatory mRNAs, as well as mSK1, mSK2, huSK1, mHSP27, and huHSP27 mRNA, were performed as described previously 58, 61 (Table 1) .
Immunoblotting analyses of kidney tissue and HK-2 cells Mouse kidney cortical tissues (including corticomedullary junction) 72 and HK-2 cell lysates 18 were collected for immunoblotting analyses as described previously. The primary antibody for murine HSP27 was obtained from Millipore (Billerica, MA). Primary antibodies for human HSP27 and human SK1 in HK-2 cells were obtained from Cell Signaling (Danvers, MA). The primary antibody for b-actin was obtained from Sigma. The secondary antibody (goat anti-rabbit and anti-mouse IgG conjugated to horseradish peroxidase in a 1:5000 dilution) was detected with enhanced chemi luminescence immunoblotting detection reagents (Amersham, Piscataway, NJ), with subsequent exposure to a CCD camera coupled to a UVP Bio-imaging System (Upland, CA) and a personal computer. The band intensities of the immunoblots were within the linear range of exposure for all experiments.
Cell culture and generation of SK1-overexpressing HK-2 cells
The generation and culture of immortalized human proximal tubule (HK-2) cells overexpressing wild-type SK1 have been described previously. 18 Induction of HK-2 cell necrosis and measurement of cell viability with LDH Necrotic injury in HK-2 cells was induced with exposure to 2 mmol/l H 2 O 2 for 3 h, and LDH released into cell culture media was measured as described. 58 
Protein determination
Protein content was determined with the Thermo Scientific bicinchoninic acid protein assay reagent with bovine serum albumin as a standard.
Statistical analysis
The data were analyzed with Student's t-test when comparing means between two groups. One-way analysis of variance plus Tukey's post hoc multiple comparison test was used when comparing multiple groups. Two-way analysis of variance plus Bonferroni post-test was used to test the effects of sham operation or renal IRI on different mouse strains or treatment groups. The ordinal values of the renal injury scores were analyzed by the Mann-Whitney nonparametric test. In all cases, a probability statistic of o0.05 was taken to indicate significance. All data are expressed throughout the text as means ± s.e.m.
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